ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Dramatic Increase In Third World Cancer Rates May Face National, International Organizations: Murphy

September 17, 1982

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987

NIH Programs: Advisory Panel Formed On Cancer and Alternative Medicine

July 16, 1999

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

SAIC Awarded $5 Billion Contract For NCI-Frederick.

October 3, 2008

In Brief: UICC Honors Dodd; Centers Recognize Nealon; Tale Expands Transplant Program

March 28, 1997